Cardiac rehabilitation should be offered to all patients following an MI, acute coronary syndrome or coronary artery bypass surgery.
For patients who have had their event or surgery in a hospital the referral should be done by secondary care.
If a patient has had a coronary event or surgery outside of Bristol or had an event more than 6 months ago then a referral can be made from primary care.
The NBT website has information for patients about their cardiac rehab team. Referrals can be emailed.
Contact details:
Email: cardiacrehab@nbt.nhs.uk
Telephone: 0117 4140040
Please note that the NBT cardiac rehab team do not follow up heart valve surgery patients.
Criteria for acceptance at UHBW - Acute MI, PPCI, PCI & CABG +/- Valve
Please note that the UHBW cardiac rehab team do not routinely follow up heart valve surgery patients unless they are performed in conjunction with Coronary Artery Bypass Grafting
For UHBW Cardiac Rehabilitation referrals for Bristol and Weston, and general enquiries email: cardiacrehab@uhbw.nhs.uk
Telephone: 0117 342 6601 for any further cardiac rehab queries.
Bristol City Council website has information about cardiac rehab services in the community for Bristol patients.
They offer follow up of patients in the community following secondary care cardiac rehab and are normally referred by these teams.
They also offer Phase IV (Health Hearts) rehab which provides ongoing exercise and maintenance of lifestyle changes in community setting. Patient leaflets, timetables and referral form are all available on their website.
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.